Takeda Pharmaceutical Company Limited (TAK)

NYSE: TAK · Real-Time Price · USD

16.77

+0.82 (5.14%)

At close: Jul 2, 2026, 4:00 PM EDT

16.85

+0.08 (0.47%)

After-hours: Jul 2, 2026, 7:46 PM EDT

Takeda Pharmaceutical Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	4,505,720	4,581,550	4,263,760	4,027,480	3,569,010
Revenue Growth (YoY)	-1.65%	7.45%	5.87%	12.85%	11.61%
Cost of Revenue	1,571,590	1,580,220	1,426,680	1,244,070	1,106,850
Gross Profit	2,934,130	3,001,330	2,837,080	2,783,410	2,462,160
Selling, General & Admin	1,084,220	1,104,770	1,053,820	997,309	886,361
Depreciation & Amortization Expenses	633,544	643,233	652,117	542,443	472,915
Research & Development	675,924	730,227	729,924	633,325	526,087
Other Operating Expenses	534,232	180,521	187,148	119,823	115,952
Total Operating Expenses	2,927,920	2,658,751	2,623,009	2,292,900	2,001,315
Operating Income	6,217	342,586	214,075	490,505	460,844
Interest Income	209,000	42,563	58,566	54,283	8,333
Interest Expense	-357,572	-210,065	-219,850	-169,698	-166,607
Total Non-Operating Income (Expense)	-148,572	-167,502	-161,284	-115,415	-158,274
Pretax Income	-142,355	175,084	52,791	375,090	302,571
Provision for Income Taxes	9,770	66,941	-91,406	58,052	72,405
Net Income	-152,125	108,143	144,197	317,038	230,166
Minority Interest in Earnings	-	-	-	21	107
Net Income to Common	-152,125	108,143	144,197	317,017	230,059
Net Income Growth	-	-25.00%	-54.51%	37.80%	-38.81%
Shares Outstanding (Basic)	3,150	3,158	3,129	3,104	3,127
Shares Outstanding (Diluted)	3,150	3,211	3,161	3,140	3,154
Shares Change (YoY)	-1.88%	1.58%	0.67%	-0.46%	0.23%
EPS (Basic)	-48.38	34.18	46.05	102.14	73.57
EPS (Diluted)	-48.38	33.62	45.58	100.97	72.94
EPS Growth	-	-26.25%	-54.86%	38.44%	-38.96%
Free Cash Flow	865,428	856,387	540,924	836,499	999,853
Free Cash Flow Growth	1.06%	58.32%	-35.34%	-16.34%	11.13%
Free Cash Flow Per Share	274.73	266.73	171.14	266.42	316.98
Dividends Per Share	200.000	196.000	188.000	180.000	180.000
Dividend Growth	2.04%	4.25%	4.44%	-	-
Gross Margin	65.12%	65.51%	66.54%	69.11%	68.99%
Operating Margin	0.14%	7.48%	5.02%	12.18%	12.91%
Profit Margin	-3.38%	2.36%	3.38%	7.87%	6.45%
FCF Margin	19.21%	18.69%	12.69%	20.77%	28.01%
EBITDA	727,344	1,103,980	942,077	1,154,910	1,044,000
EBITDA Margin	16.14%	24.10%	22.10%	28.68%	29.25%
EBIT	6,217	342,586	214,075	490,505	460,844
EBIT Margin	0.14%	7.48%	5.02%	12.18%	12.91%
Effective Tax Rate	-6.86%	38.23%	-173.15%	15.48%	23.93%

SEC Filings: 10-K · 10-Q